Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01096368
Title Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Children's Oncology Group

papillary ependymoma

clear cell ependymoma

brain ependymoma

cellular ependymoma


Carboplatin + Cyclophosphamide + Vincristine sulfate liposome

Carboplatin + Etoposide + Vincristine sulfate liposome

Cisplatin + Cyclophosphamide + Etoposide

Cisplatin + Cyclophosphamide + Etoposide + Vincristine sulfate liposome

Age Groups: child | adult
Covered Countries USA | CAN

No variant requirements are available.